We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Clears Kensey Nash System; Company Commences New Trial
FDA Clears Kensey Nash System; Company Commences New Trial
April 1, 2005
The FDA granted Kensey Nash clearance on March 30 to market its TriActiv Embolic Protection System in the U.S. for the prevention of heart attacks during the interventional treatment of saphenous vein grafts (SVGs).